Complexes of binucleating ligands. XIX. Facile hydration of nitriles at a di-palladium(II) site under mild conditions

The acetate-bridged complex LPd₂(CH₃CO₂), in which L³⁻ is a previously reported binucleating ligand, reacts with hydroxide ion to generate hydroxo-LPd₂ which, molecular weight measurements suggest, exists as [LPd₂(OH)]₃₋₄ in chloroform solution. Hydroxo-LPd₂ reacts with nitriles at room temperature to yield the complex with the conjugate base of the corresponding amide bound at the di-palladium site. It is proposed that this unusually facile hydration of nitriles proceeds via a non-bridged intermediate in which the nitrile is bound to one palladium centre and thereby activated to nucleophilic attack, whilst the nucleophilic hydroxide is held in close proximity, bound to the second palladium.     

H2O2 reactivity of a dinuclear copper(II) complex incorporating a constrained binucleating polyaminopyridyl ligand and a phosphodiester coligand

A dinuclear copper(II) complex [Cu₂(PD)(DPP⁻)₂](ClO₄)₂ (1) incorporating a constrained binucleating hexadenate ligand, PD (1,3-bis{bis[(2-pyridyl)ethyl]amino}benzene), and coligand, DPP⁻ (diphenylphosphate) was synthesized and characterized, with a specific outlook towards evaluating spectroscopic and H₂O₂ reactivity relevant to the active-sites of noncoupled dinuclear copper enzymes, DβM and PHM. In solution, complex 1 exhibits a broad ¹H NMR in the range −25 to +60 ppm and has a solution magnetic moment (μ) of ∼2.0 B.M./Cu(II), typical of a noninteracting dicopper(II) center. The room temperature H₂O₂ reactivity of 1 monitored by UV-Vis spectroscopy reveals the formation of a copper(II)-dioxygen intermediate 1a, which in turn leading to a arene ligand hydroxylation (PD-O⁻) and thus provide a new doubly-bridged dicopper(II) complex, [Cu₂(PD-O⁻)(DPP⁻)](ClO₄)₂ (2). The dioxygen intermediate produces OPPh₃ on treatment with PPh₃ revealing it is an electrophilic hydroperoxide oxidant. Solution magnetic moment of 1.61 B.M./Cu(II) indicates the product complex 2 is a moderately interacting dicopper(II) center and its ¹H NMR spans between −20 and +180 ppm. A comparison of the optical absorption features of complex 1a with related dinuclear hydroperoxo-copper(II) complexes is discussed.     

Ternary copper(II) complexes involving 2-(aminomethyl)-benzimidazole and some bio-relevant ligands. Equilibrium studies and kinetics of hydrolysis for glycine methyl ester under complex formation

Formation equilibria of copper(II) complexes of 2-(aminomethyl)-benzimidazole (AMBI) and the ternary complexes Cu(AMBI)L (L = amino acid, amide, dicarboxylic acid or DNA constituents) have been investigated. Ternary complexes of amino acids or amides are formed by a simultaneous mechanism. Amino acids form the complex Cu(AMBI)L, whereas amides form two complex species Cu(AMBI)L and Cu(AMBI)(LH₋₁). The ternary complexes of copper(II) with AMBI and dicarboxylic acids or DNA units are formed by a stepwise mechanism, whereby binding of copper(II) to AMBI is followed by ligation of the dicarboxylic acids or DNA components. The values of Δ log K indicate that the ternary complexes containing aromatic amino acids are significantly more stable than the complexes containing alkyl- and hydroxyalkyl-substituted amino acids. This may be taken as an evidence for a stacking interaction between the aromatic moiety of AMBI and the aromatic side chains of the bio-active ligands. The solid complexes Cu(AMBI)L where L = 1,1-cyclobutanedicarboxylic acid (CBDCA) and malonic acid were separated and identified by elemental analysis and infrared spectroscopy and magnetic moment. The decomposition course and steps for the isolated complexes were analyzed and the kinetic parameters of the non-isothermal decomposition were calculated. The hydrolysis of glycine methyl ester (MeGly) is catalyzed by the Cu(AMBI)²⁺ complex. The kinetic data is fitted assuming that the hydrolysis reaction proceeds in two steps. The first step, involving coordination of the amino acid ester by the amino and carbonyl groups, is followed by rate-determining attack by OH⁻ ion. The second step involves the equilibrium formation of the hydroxo-complex Cu(AMBI)(MeGly)(OH) followed by intramolecular OH⁻ attack.     

Complexes of hybrid ligands. Synthesis of mixed-ligand,phosphino-alkoxide complexes of Pd2+: the crystal and molecular structure of the complex Ph2 PCH2C(CF3 )2OPdCl(PPh2Me)

The hybrid, bidentate, diarylphosphino-alkoxide ligand PPh₂CH₂C(CF₃)₂O⁻, L¹, gives the Pd²⁺ bis- complex Pd(L¹)₂, from which the chloride-bridged dinuclear complex [(L¹)Pd(μ-Cl)₂Pd(L¹)] is made by reaction with PdCl₂(PhCN)₂. Cleavage of the dinuclear complex with monodentate ligands L² then gives Pd(L¹)Cl(L²) (L² =PPh₃, PPh₂Me, PPhMe₂, PMe₃, SMe₂, or pyridine); NMR data show that PR₃ is cis to the phosphine site in L¹ in these complexes, but SMe₂ or pyridine are probably trans.A complete crystal and molecular structural determination has been made for cis-Pd(L¹)Cl(PPh₂Me). Crystals are monoclinic, space group P2₁/c, a = 10.821(1), b = 14.600(1), c = 18.674(2) Å, β = 101.25(1)°, V = 2893 ų, Z = 4. Least-squares refinement on F of 361 variables using 3977 observations converged at a conventional agreement factor R = 0.025. The complex is square-planar, with the two phosphines cis; the 5-membered chelate ring is in a dissymmetric envelope conformation. The PdP bonds differ in length, with that to the unidentate phosphine, 2.259(1) Å, being significantly longer than that to the phosphine on the chelating ligand, 2.231(1) Å.     

The preparation and crystal structure analysis of a 2:1 complex between L-lysine and copper(II) chloride

The crystal structure of bis(L-lysine)Cu(II) chloride dihydrate has been determined by X-ray analysis. The complex crystallizes in the monoclinic space group P2₁, with cell dimensions a = 5.189(1), b = 16.988(3), c = 11.482(2) Å, β = 93.57(1)°. The position of the Cu atom was found from a Patterson synthesis, the remaining atoms were located with DIRDIF. The structure was refined by least-squares to R = 0.060 and R_w = 0.065 for 2637 observed reflections. The copper(II) atom has an essentially square planar coordination with the two lysine molecules chelated via the carboxy oxygen and the α-amino nitrogen. However the two chlorine atoms form weak interactions with the metal to complete a strongly tetragonally elongated six-fold coordination. The two aliphatic chains have rather different geometries and are extended in a zig-zag mode. Extensive hydrogen bonding links the complex and the water molecules together.     

Synthesis and characterization of a novel Pd(II) complex with the condensation product of 2-(diphenylphosphino)benzaldehyde and ethyl hydrazinoacetate. Cytotoxic activity of the synthesized complex and related Pd(II) and Pt(II) complexes

A new palladium(II) complex 1 of the condensation product of 2-(diphenylphosphino)benzaldehyde (dpba) and ethyl hydrazinoacetate (etha) was synthesized and characterized by elemental analyses, IR, and (1)H NMR spectroscopy. The bound ligand is a bidentate (PN chromophore), the remaining two coordination places being occupied by chloride ions in overall square planar geometry. The cytotoxic activity of the complex 1 and two related Pd(II) and Pt(II) complexes 2 and 3 was tested against a panel of four tumor cell lines. The activity of the complexes was similar to that of cisplatin, the most widely used metal-based antitumor drug. It is important to notice that complexes 2 and 3 were active to cisplatin-resistant U2-OS/Pt cells. Cell cycle alteration investigation, apoptotic assay and gelatin zymography in relation to invasion and metastasis of tumor cells, were performed with all the investigated complexes on Human cervix carcinoma (HeLa) cells. The results suggest that 1 has a similar effect to cisplatin, inducing apoptosis followed by arrest of cells in S phase of cell cycle, while 2 and 3 induce apoptosis without significant perturbations of cell cycle distribution.     

Coordination properties of ethyl bis(pyridin-2-ylmethyl)phosphate ligand with copper and zinc chloride. X-ray crystal structure of Cu(II) complex

A new ethyl bis(pyridin-2-ylmethyl)phosphate (2-bis(pm)Ope) ligand has been synthesized and used for synthesis of copper(II) and zinc(II) complexes of the formula [MCl₂(2-bis(pm)Ope)] [M = Cu(II), Zn(II)]. Despite having the same general formula, Cu(II) and Zn(II) complexes are not isostructural. The Zn(II) complex is four coordinated (MCl₂N₂) forming probably tetrahedral structure whereas the Cu(II) complex of distorted square pyramidal geometry is five coordinated (MCl₂ON₂). The later compound not only coordinates by two nitrogen atoms of pyridine rings but also by the oxygen atom of pyridin-2-ylmethoxyl residue. The compound (2-bis(pm)Ope) has been obtained as the product of diethyl (pyridin-2-ylmethyl)phosphate’s (2-pmOpe) transestrification. The compounds have been identified and characterized by IR, far-IR, ¹H NMR, ³¹P NMR and elemental analyses. The crystal structure of copper(II) complex i.e. [CuCl₂(2-bis(pm)Ope)] has been determined by the X-ray diffraction method. The low temperature magnetic study reveals significant antiferromagnetic interaction between copper centers through the H-bond system.     

New macrocyclic Schiff-base complexes incorporating a phenanthroline unit. Part 2: Template synthesis of some manganese(II) complexes and crystal structure studies

A series of Mn(II) macrocyclic Schiff-base complexes [MnLⁿ]²⁺ have been prepared via the Mn(II) templated [1+1] cyclocondensation of 2,9-dicarboxaldehyde-1,10-phenanthroline with appropriate linear and branched amines. In this way ligands the pentaaza macrocycle L¹ which is 15-membered and L² which is 16-membered possessing no pendant arm, L⁶ is 15-membered with one 2-aminoethyl pendant arm and L⁸ which is 18-membered hexaaza macrocycle with two 2-aminoethyl pendant arms are formed. All the complexes have been characterized using spectroscopic methods. The crystal structures of [MnL⁸](ClO₄)₂ · EtOH were determined and indicate that in the solid state the complex adopts a slightly distorted hexagonal bipyramid geometry with the Mn(II) ion located within a hexaaza macrocycle with the two pendant amines coordinating in the axial positions.     

Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory properties.

The synthesis and characterization of three complexes with a potent nonsteroidal anti-inflammatory drug niflumic acid {2-[3-(trifluoromethyl)phenyl]aminonicotinic acid} with formula [Cu(niflumato)2L] (L = H2O, DMSO = dimethylsulfoxide, DMF = N,N-dimethylformamide) were investigated. The crystal and molecular structure of the {Cu(niflumato)2(DMSO)}2 was reported. Crystallographic data are as follows: monoclinic system, space group P2(1)/n, Z = 2, a = 11.1318(8), b = 17.513(2), c = 15.336(1) A, beta = 103.316(8) degrees, V = 2909.4(4) A3. The structure was refined to R = 0.030 and wR = 0.037 for 3702 reflections with I > sigma (I). It consists of centrosymmetric binuclear units with the Cu-Cui (symmetry code i: 1-x, -y, 1-z) distance between two centrosymmetrically related ions of 2.6272(5) A. Each Cu(II) ion in [Cu2(DMSO)2(mu-niflumato)4] is coordinated to an apical dimethylsulfoxide O atom on the one hand and to the equatorial carbonyl and carboxylic O atoms of two crystallographically independent niflumate moieties and their centrosymmetric counterparts on the other hand. In spite of the low-temperature (190 K) crystal measurements, one L-CF3 grouping exhibits some disorder. The biological activities of these complexes were compared to that of niflumic acid. Niflumic acid and its various copper complexes significantly inhibited polymorphonuclear leukocyte (PMNL) oxidative metabolism, as assessed by chemiluminescence and O2- generation measurement. This effect was dose-dependent. All copper complexes exerted a similar inhibiting effect which was always significantly higher than that exerted by the parent drug.     

Manganese(II) tri-tert-butoxysilanethiolate complexes with imidazole-based coligands: a neutral complex with four independent ligands and MNOS2 core (M=Mn) related to the liver alcohol dehydrogenase catalytic center (M=Zn)

The reaction of [Mn{SSi(OBu(t))3}2(MeOH)4] with imidazole and its two methyl substituted derivatives leads to different types of heteroleptic manganese(II) thiolate complexes. Reaction with 1-methylimidazole gives the silanethiolate devoid of methanol but with two nitrogen ligands and thus central MnN(2)S(2) core. The reaction with imidazole leads to the methanol solvated complex with only one nitrogen ligand but manganese coordination sphere enlarged to MnO(2)NS(2) due to an O,S-chelation by tri-tert-butoxysilanethiolate ligand. Molecules of this compound interact through a set of N-H...(Me)O-H...S hydrogen bonds with methanol hydroxyl group being simultaneously acceptor and donor. With 2-methylimidazole the product is an assembly of two different neutral complexes joined again by hydrogen bonds, however, this time of N-H...S type. One of these complexes has the previously mentioned MnO(2)NS(2) core. The second neutral complex exhibits four donor atoms (MnNOS(2)core) derived from four independent ligands, i.e., two silanethiolate rests, one N-heterocyclic base and one alcohol. This structure presents similarities with a zinc-based alcohol dehydrogenase active site that have never been obtained before, including with other metals (Zn, Co). It may, therefore, be considered the first neutral structural model of liver alcohol dehydrogenase (LADH).     

Site-directed mutagenesis of a loop at the active site of E1 (alpha2beta2) of the pyruvate dehydrogenase complex. A possible common sequence motif.

Limited proteolysis of the pyruvate decarboxylase (E1, alpha2beta2) component of the pyruvate dehydrogenase (PDH) multienzyme complex of Bacillus stearothermophilus has indicated the importance for catalysis of a site (Tyr281-Arg282) in the E1alpha subunit (Chauhan, H.J., Domingo, G.J., Jung, H.-I. & Perham, R.N. (2000) Eur. J. Biochem. 267, 7158-7169). This site appears to be conserved in the alpha-subunit of heterotetrameric E1s and multiple sequence alignments suggest that there are additional conserved amino-acid residues in this region, part of a common pattern with the consensus sequence -YR-H-D-YR-DE-. This region lies about 50 amino acids on the C-terminal side of a 30-residue motif previously recognized as involved in binding thiamin diphosphate (ThDP) in all ThDP-dependent enzymes. The role of individual residues in this set of conserved amino acids in the E1alpha chain was investigated by means of site-directed mutagenesis. We propose that particular residues are involved in: (a) binding the 2-oxo acid substrate, (b) decarboxylation of the 2-oxo acid and reductive acetylation of the tethered lipoyl domain in the PDH complex, (c) an "open-close" mechanism of the active site, and (d) phosphorylation by the E1-specific kinase (in eukaryotic PDH and branched chain 2-oxo acid dehydrogenase complexes).     

X-ray crystal structure of Cu2(medpco-2H)Cl2, (medpco = N,N′-bis(2-N,N-dimethylaminoethyl)pyridine-2,6-dicarboxamide 1-oxide. Copper(II) complexes of a deprotonated binucleating pyridine N-oxide ligand

The X-ray structure is reported for the complex Cu₂(medpco-2H)Cl₂, (medpco = N,N′-bis-N,N-dimethylaminoethyl)pyridine-2,6-dicarboxamide 1-oxide. The complex is triclinic, , a=8.313(4), B=11.403(5), C=11.611(3) Å, =91.66(3), β=108.99(4), γ=109.60(3)° and Z=2. The deprotonated ligand (medpco-2H)²⁻ acts as a binulceating ligand, producing an N-oxide-bridged complex. Each copper in Cu₂(medpco-2H)Cl₂ is five-coordinate, being coordinated by a bridging N-oxide oxygen, a deprotonated amide nitrogen, a tertiary amine nitrogen and two bridging chlorides. The complex does not exhibit significant magnetic interaction, and this may be the result of distortion of the bridging geometry from planarity. A range of other, apparently N-oxide-bridged, complexes of the type Cu₂(medpco-2H)X₂ is reported. The complex Cu₂(medpco-2H)Br₂·H₂O is strongly antiferromagnetic, with magnetic data closely fitting the expected binuclear structure.     

Reactivity of [MO] (M = Tc, Re) core towards 2-mercapto-1,3-azole ligands. Formation of a new organometallic complex of Re(IV) and X-ray crystal structures

Imidazole-2-thiol derivatives H₂L^1-3 (H₂L¹ = 1H-benzoimidazole-2-thiol, H₂L² = 5-methyl-1H-benzoimidazole-2-thiol, and H₂L³ = 1H-imidazole-2-thiol) act as neutral monodentate ligands in a number of technetium and rhenium complexes. Disubstituted M(V) (M = Tc, Re) complexes of the type [AsPh₄]{[MOCl₂(H₂Lⁿ)₂(H₂O)]Cl₂} are formed when [MOCl₄]⁻ react with H₂L^1-3 in 1:2 stoichiometric ratio. Single crystal X-ray structure determinations were carried out on [AsPh₄]{[TcOCl₂(H₂L¹)₂(H₂O)]Cl₂}. The coordination sphere is pseudo-octahedral in which the sulfur atoms of two ligands sit in the equatorial plane and a water molecule is in trans to the TcO multiple bond. All the complexes react with an excess of the corresponding ligand to form tetrasubstituted cationic species {[MO(H₂Lⁿ)₄]Cl₃}. These complexes can be also isolated by reaction of [MOCl₄]⁻ with an excess of ligand. No complex is obtained with benzothiazole-2-thiol (HL⁴) and benzoxazole-2-thiol (HL⁵). Ligand exchange reactions of [ReOCl₃(PPh₃)₂] with HL^4,5 have also been investigated. Treating the oxo-precursor with HL⁴ no product is isolated, while with HL⁵ the chelate oxo-compound [ReOCl₂(L⁵)(PPh₃)] is formed as two isomers. An interesting organometallic complex of Re(IV) [ReCl₃(L^5∗)(PPh₃)₂] is obtained when a slight excess of HL⁵ reacts with [ReOCl₃(PPh₃)₂] in refluxing benzene solution and in air. Geometry about the Re atom is approximately octahedral in which the equatorial plane contains three Cl atoms and the carbon atom of the benzoxazole ligand anion, the apical positions are occupied by two PPh₃. The reaction with O-ethyl S-hydrogen p-tolyl carbonothioimidate HL⁶ which contains the same heteroatoms of HL⁵ does not form an organometallic species, but forms the chelate oxo-Re(V) complex [ReOCl₂(L⁶)(PPh₃)]. The solid-state structure has been authenticated by X-ray crystallography.     

Kinetics of imidazole addition to the axial site of the iron(II) complex of 2, 3, 9,10-tetraphenyl-1,4, 8,11-tetraaza-1,3, 8,10-cyclotetradecatetraene in dimethyl sulfoxide. Evidence for a dissociative-interchange mechanism

The axial adduct formation of the iron(II) complex of 2,3,9,10-tetraphenyl-l,4,8,11-tetraaza-1,3,8,10-cyclotetradecatetraene (L) with imidazole in dimethyl sulfoxide has been investigated spectrophotometrically at various temperatures and pressures. In the presence of a large excess of imidazole the reaction with the two phases has been observed. The first faster reaction is the formation of the monoimidazole complex of FeL²⁺, and the second slower reaction corresponds to the formation of the bisimidazole complex. Activation parameters are as follows: for the first step with k₁ (25.0°C) = (6.8 ±0.2)×10⁵ mol⁻¹ kg s⁻¹, ΔH³₁ = 47.5 ± 4.9 kJ mol⁻¹, ΔS³₁ = 26±16 J K⁻¹ mol⁻¹, and ΔV³₁ (30.0°C) = 27.2±1.5 cm³ mol⁻¹; for the second step with k₂ (25.0°C) = 26.8±0.8 mol⁻¹ kg s⁻¹, ΔH³₂ = 91.6± 0.8 kJ mol⁻¹, ΔS³₂ = 90±3 J K⁻¹ mol⁻¹, and ΔV³₂ (35.0°C) = 21.8±0.9 cm³ mol⁻¹. The large positive activation volumes strongly indicate a dissociative character of the activation process.     

Coordination fluxionality of copper(II) with a sterically constrained Pyrazole-containing chelating ligand. crystal and molecular structure at 298 K and 140 K of=1,6-Bis(3,5-dimethylpyrazol-1-yl)-2,5-dimethyl-2,5-diazahexane-bis(thiocyanato-N)copper(II), [C18H28CuN8S2]

The X-ray structure determinations of the compound Cu(debd)(NCS)₂ at 140 K and at 298 K showed at both temperatures a tetragonal crystal system with space group P4₁2₁2 (Z=4) and a molecular C₂ symmetry. Cell dimensions are: a= 9.577, c=24.422 Å and V=2240 ų at 140 K, and a=9.614, c=24.854 Å and V=2297 ų at 298 K. 1218 (140 K) and 1057 (298 K) reflections with I > 1.96 σ(I) were used for the solution to a final R_w value of 0.036 (140 K) and 0.032 (298 K). The copper(II) environment is roughly octahedral. The copper to nitrogen bonds vary with temperature: Cu-N(amine)=2.242 Å (140 K) and 2.191 Å (298 K), Cu-N(pyrazole)=2.099 Å (140 K) and 2.193 Å (298 K), and Cu-NCS=2.060 Å (140 K) and 2.034 Å (298 K). The ESR spectra of the Cu(II)- doped isomorphous Zn(II) and Cd(II) compounds, which have been measured at ambient temperature, at 77 K, and at 3 K, clearly reflect the temperature dependence of the structure.     

The trans influence of F, Cl, Br and I ligands in a series of square-planar Pd(II) complexes. Relative affinities of halide anions for the metal centre in trans-[(Ph3P)2Pd(Ph)X]

Single crystal X-ray diffraction studies of trans-[(Ph₃P)₂Pd(Ph)X] (X = F (1), Cl (2), Br (3), and I (4) were carried out. The four structures split in two isostructural and isomorphous groups, namely orthorhombic for 1 and 2 (space group Pbca, Z = 8) and triclinic for 3 and 4 (space group P-1, Z = 2). According to the Pd---C bond length, the trans influence of X within these pairs follows the trend Cl>F and 1>Br. However, the trans influence of Cl is slightly stronger than that of Br. Both structural and ¹³C NMR studies revealed that electron-donating effects of (Ph₃P)₂PdX increase along the series X=I− for the Pd centre in [(Ph₃P)₂Pd(Ph)]⁻ were studied by ³¹P NMR in rigorously anhydrous CH₂Cl₂ solutions, and equilibrium constants and ΔG values were obtained for all possible combinations. The sequence F⁻ > Cl⁻ > Br⁻ > I⁻ is characteristic of halide preference for the Pd complexes. Dissolving 1 and PPN Cl in dry CH₂Cl₂ resulted in the release of ‘naked’ F⁻ which fluorinated the solvent smoothly to give a mixture of CH₂ClF and CH₂F₂ in high yield. When chloroform was used instead of CH₂Cl₂, dichlorocarbene was generated slowly, forming the corresponding cyclopropane in the presence of styrene. All observations were rationalized successfully in terms of the filled/filled effect and push/pull interactions.     

Metal-penicillamine interactions. Part 1. Preparation and crystal structure of a 1:1 complex of mercuric chloride with d-penicillamine, 2[μ3-Cl){HgSC(CH3)2CH(NH3)COO}3·3(μ2-Cl)· 2(H3O)·(H2O·Cl)3

A 1:1 complex of mercuric chloride with D-peniccillamine has been isolated and characterised as 2[(μ₃-Cl){HgSC(CH₃)₂CH(NH₃)COO}3]·3(μ₂-Cl)·2(H₃O)·(H₂O·Cl)₃. The compound crystallises in cubic space group P4₁32, with a = 18.679(5) Å and Z = 4. The structure, refined to R_F = 0.086 for 443 observed Mo-Kα diffractometer data, features a triply bridging chloride ion linking three equivalent [HgSC(CH₃)₂CH(NH₃)COO]⁺ units [Hg-Cl = 2.37(1) Å, Hg-Cl-Hg′ = 98.5(9)°]. The carboxylate groups of a pair of adjacent penicillamine ligands are strongly linked via a symmetrical O?H?O hydrogen bond of length 2.24(8) Å, and neighboring pyramidal trinuclear [μ₃-Cl){HgSC(CH₃)₂CH(NH₃)-COO}₃]²⁺ moieties are further connected by symmetrical chloride bridges [Hg-Cl = 3.06(2) Å; HgClHg′' = 79.6(7)°] to form a three-dimensional network. The voids in the lattice are filled by hydronium ions and novel planar cyclic hydrogen-bonded (H₂O·Cl^?)₃ rings of edge O-H?Cl = 2.46(4) Å.